Pharmaceutical

Roche wins first approval for subcutaneous Tecentriq

The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.

Aug 30, 2023 - 20:00
Roche wins first approval for subcutaneous Tecentriq
The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.
Read the original article

Tags:

Previous Article

Codagenix pursues RSV vaccine development amid unexpected challenges

Next Article

Signal: PureHealth UK expansion shows continued focus on healthcare in UAE

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CDC eases isolation guidance for Covid and other respiratory illnesses

CDC eases isolation guidance for Covid and other respir...

Mar 2, 2024

Not the geek squad: How one health system helps patients conquer language barriers — and their smartphones

Not the geek squad: How one health system helps patient...

Mar 24, 2023

STAT+: House panel passes public health bills following contentious debate

STAT+: House panel passes public health bills following...

Jul 14, 2023